Enovix Co. (NASDAQ:ENVX – Get Free Report) Director Gregory Reichow sold 7,500 shares of Enovix stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $12.14, for a total transaction of $91,050.00. Following the completion of the sale, the director now directly owns 8,129 shares of the company’s stock, valued at approximately $98,686.06. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Enovix Stock Performance
NASDAQ ENVX opened at $15.03 on Thursday. Enovix Co. has a 12 month low of $5.70 and a 12 month high of $23.90. The company’s 50 day moving average is $9.97 and its two-hundred day moving average is $10.09. The company has a debt-to-equity ratio of 0.72, a quick ratio of 4.77 and a current ratio of 4.89.
Enovix (NASDAQ:ENVX – Get Free Report) last released its earnings results on Wednesday, May 1st. The company reported ($0.39) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.05). Enovix had a negative net margin of 1,448.90% and a negative return on equity of 85.47%. The firm had revenue of $5.27 million for the quarter, compared to analysts’ expectations of $4.16 million. As a group, equities research analysts expect that Enovix Co. will post -1.15 EPS for the current fiscal year.
Institutional Trading of Enovix
Wall Street Analysts Forecast Growth
Several analysts recently commented on ENVX shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a report on Thursday, April 25th. B. Riley reduced their price target on shares of Enovix from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. William Blair reissued an “outperform” rating on shares of Enovix in a report on Thursday, May 2nd. JPMorgan Chase & Co. reduced their target price on shares of Enovix from $18.00 to $12.00 and set an “overweight” rating for the company in a report on Friday, April 26th. Finally, Craig Hallum dropped their price target on shares of Enovix from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $18.33.
View Our Latest Report on Enovix
About Enovix
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
- Five stocks we like better than Enovix
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- Options Trading – Understanding Strike Price
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- What is the NASDAQ Stock Exchange?
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.